Profil
Dr. Anders Vahlne is Chief Executive Officer, Director & Head-Research at Chrontech Pharma AB, a Professor at Karolinska Institutet, and a Member at University College Dublin.
He is on the Board of Directors at Chrontech Pharma AB.
Dr. Vahlne was previously employed as Head-Research by Tripep AB.
Postes actifs de Anders Vahlne
| Sociétés | Poste | Début |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/11/2010 |
University College Dublin
University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/11/2010 |
Anciens postes connus de Anders Vahlne
| Sociétés | Poste | Fin |
|---|---|---|
Fastilium Property Group AB
Fastilium Property Group AB Real Estate DevelopmentFinance Engages in the development and management of residential and commercial properties | Directeur Général | 17/12/2014 |
Din Bostad Sverige AB
Din Bostad Sverige AB Real Estate DevelopmentFinance Operates a residential property business | Directeur Technique/Scientifique/R&D | 01/01/2006 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Din Bostad Sverige AB
Din Bostad Sverige AB Real Estate DevelopmentFinance Operates a residential property business | Finance |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fastilium Property Group AB
Fastilium Property Group AB Real Estate DevelopmentFinance Engages in the development and management of residential and commercial properties | Finance |
















